Cargando…

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Oh, Sooyeon, Lee, Jooho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641548/ https://www.ncbi.nlm.nih.gov/pubmed/33053929 http://dx.doi.org/10.3350/cmh.2020.0192

Ejemplares similares

Mechanisms of sarcopenia in liver cirrhosis and the role of myokines
por: Geladari, Eleni, et al.
Publicado: (2023)

Sclerostin as a Putative Myokine in Sarcopenia
por: Yi, Hyon-Seung
Publicado: (2022)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Liver cirrhosis and sarcopenia: a dreadful combination
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
por: Oh, Hyunwoo, et al.
Publicado: (2020)

Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications
por: Barbalho, Sandra Maria, et al.
Publicado: (2020)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Prognostic Assessment and Management of Liver Cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2017)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2023)

Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk
por: Scisciola, Lucia, et al.
Publicado: (2021)

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Myostatin and beyond in cirrhosis: all roads lead to sarcopenia
por: Dasarathy, Srinivasan
Publicado: (2017)

Brain and Brawn: Role of Exercise-Induced Myokines
por: Bae, Jun Hyun, et al.
Publicado: (2019)

The sex‐specific prognostic utility of sarcopenia in cirrhosis
por: Lowe, Ryan, et al.
Publicado: (2022)

Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China
por: Zeng, Xin, et al.
Publicado: (2021)

Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines
por: Bilski, Jan, et al.
Publicado: (2022)

Prognostic implications of trunk muscle mass in liver cirrhosis
por: Han, Jimin, et al.
Publicado: (2018)

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
por: Oh, Sooyeon, et al.
Publicado: (2020)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Myokines: Crosstalk and Consequences on Liver Physiopathology
por: Dumond Bourie, Aurore, et al.
Publicado: (2023)

Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma?
por: Silva, Mauricio F., et al.
Publicado: (2013)

Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis
por: Marasco, Giovanni, et al.
Publicado: (2022)

Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2021)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

Finding good biomarkers for sarcopenia
por: Scharf, Gesine, et al.
Publicado: (2012)

Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening
por: Simão, Adélia, et al.
Publicado: (2015)

Sarcopenia and Liver Cirrhosis—Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019
por: Traub, Julia, et al.
Publicado: (2020)

Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2015)

Consilience in sarcopenia of cirrhosis
por: Dasarathy, Srinivasan
Publicado: (2012)

Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2021)

A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma
por: Effenberger, Maria, et al.
Publicado: (2023)

Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast-enhanced ultrasound and pathology
por: He, Yukai, et al.
Publicado: (2018)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75nde0mtdpsvu5ob7jaj72obd3